Smith & Nephew SNATS PE Ratio 2012-2026 | SNN
Current and historical p/e ratio for Smith & Nephew SNATS (SNN) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Smith & Nephew SNATS PE ratio as of September 14, 2026 is 0.00.
| Smith & Nephew SNATS PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-15 | 28.01 | 0.00 | |
| 2026-06-30 | 28.81 | 0 | 0.00 |
| 2025-12-31 | 32.32 | 0 | 0.00 |
| 2025-06-30 | 29.92 | 0 | 0.00 |
| 2024-12-31 | 23.62 | 0 | 0.00 |
| 2024-06-30 | 23.59 | 0 | 0.00 |
| 2023-12-31 | 25.48 | 0 | 0.00 |
| 2023-06-30 | 29.76 | 0 | 0.00 |
| 2022-12-31 | 24.40 | 0 | 0.00 |
| 2022-06-30 | 25.01 | 0 | 0.00 |
| 2021-12-31 | 30.57 | 0 | 0.00 |
| 2021-06-30 | 38.05 | 0 | 0.00 |
| 2020-12-31 | 36.49 | 0 | 0.00 |
| 2020-06-30 | 32.74 | 0 | 0.00 |
| 2019-12-31 | 40.72 | 0 | 0.00 |
| 2019-06-30 | 36.65 | 0 | 0.00 |
| 2018-12-31 | 31.12 | 0 | 0.00 |
| 2018-06-30 | 31.01 | 0 | 0.00 |
| 2017-12-31 | 28.58 | 0 | 0.00 |
| 2017-06-30 | 28.26 | 0 | 0.00 |
| 2016-12-31 | 24.10 | $0.36 | 66.95 |
| 2015-12-31 | 28.00 | $0.59 | 47.46 |
| 2015-06-30 | 26.53 | $0.79 | 33.58 |
| 2014-12-31 | 28.40 | $1.13 | 25.22 |
| 2014-09-30 | 25.86 | $1.13 | 22.97 |
| 2014-06-30 | 27.42 | $1.16 | 23.56 |
| 2014-03-31 | 23.22 | $1.25 | 18.61 |
| 2013-12-31 | 21.78 | $1.23 | 17.74 |
| 2013-09-30 | 18.79 | $1.18 | 15.87 |
| 2013-06-30 | 16.88 | $1.22 | 13.88 |
| 2013-03-31 | 17.13 | $1.59 | 10.79 |
| 2012-12-31 | 16.44 | $1.63 | 10.07 |
| 2012-09-30 | 16.20 | $1.63 | 9.95 |
| 2012-06-30 | 14.70 | $1.63 | 9.03 |
| 2012-03-31 | 14.68 | $1.31 | 11.19 |
| 2011-12-31 | 14.00 | $1.30 | 10.77 |
| 2011-09-30 | 12.90 | $1.40 | 9.24 |
| 2011-06-30 | 15.63 | $1.40 | 11.20 |
| 2011-03-31 | 16.14 | $1.36 | 11.83 |
| 2010-12-31 | 15.04 | $1.38 | 10.93 |
| 2010-09-30 | 12.90 | $1.26 | 10.27 |
| 2010-06-30 | 13.36 | $1.24 | 10.74 |
| 2010-03-31 | 14.11 | $1.20 | 11.72 |
| 2009-12-31 | 14.44 | $1.06 | 13.58 |
| 2009-09-30 | 12.61 | $1.04 | 12.17 |
| 2009-06-30 | 10.43 | $0.91 | 11.49 |
| 2009-03-31 | 8.65 | $0.87 | 9.92 |
| 2008-12-31 | 8.94 | $0.84 | 10.64 |
| 2008-09-30 | 14.62 | $0.80 | 18.18 |
| 2008-06-30 | 15.07 | $0.68 | 22.30 |
| 2008-03-31 | 18.07 | $0.68 | 26.57 |
| 2007-12-31 | 15.72 | $0.68 | 22.98 |
| 2007-09-30 | 16.70 | $0.76 | 21.86 |
| 2007-06-30 | 16.92 | $0.77 | 21.92 |
| 2007-03-31 | 17.22 | $0.76 | 22.78 |
| 2006-12-31 | 14.20 | $1.44 | 9.83 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $11.926B | $6.164B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |